A novel capecitabine dosing schedule combined with bevacizumab is safe and active in patients with metastatic breast cancer: A phase II study Meeting Abstract
| Authors: | Traina, T. A.; Theodoulou, M.; Dugan, U.; Feigin, K.; Patil, S.; Edwards, C.; Norton, L.; Hudis, C. A. |
| Abstract Title: | A novel capecitabine dosing schedule combined with bevacizumab is safe and active in patients with metastatic breast cancer: A phase II study |
| Meeting Title: | 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 26 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2008 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2008-05-20 |
| Start Page: | 66s |
| Language: | English |
| ACCESSION: | WOS:000208457400242 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2008.26.15_suppl.1101 |
| Notes: | Meeting Abstract: 1101 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
